Agilent Technologies, Inc. $A Shares Purchased by Gateway Investment Advisers LLC

Key Points

• Gateway Investment Advisers LLC significantly increased its stake in Agilent Technologies, acquiring an additional 102,362 shares, bringing its total ownership to approximately 167,191 shares valued at about $19.73 million.
• Agilent Technologies reported a 10.1% year-over-year increase in revenue for the quarter, posting earnings per share (EPS) of $1.37, meeting analysts' estimates on revenue of $1.74 billion.
• Analysts have mixed views on Agilent Technologies, with six giving it a Buy rating while others downgraded the stock from "buy" to "hold," reflecting uncertainty in future performance.

Gateway Investment Advisers LLC boosted its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 157.9% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 167,191 shares of the medical research company's stock after buying an additional 102,362 shares during the quarter. Gateway Investment Advisers LLC owned 0.06% of Agilent Technologies worth $19,730,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Aaron Wealth Advisors LLC purchased a new position in Agilent Technologies during the second quarter worth $270,000. Financiere des Professionnels Fonds d investissement inc. boosted its stake in Agilent Technologies by 19.5% during the second quarter. Financiere des Professionnels Fonds d investissement inc. now owns 100,301 shares of the medical research company's stock worth $11,837,000 after buying an additional 16,346 shares during the period. Dudley & Shanley Inc. boosted its stake in Agilent Technologies by 12.2% during the second quarter. Dudley & Shanley Inc. now owns 55,200 shares of the medical research company's stock worth $6,514,000 after buying an additional 6,000 shares during the period. Czech National Bank boosted its stake in Agilent Technologies by 6.4% during the second quarter. Czech National Bank now owns 69,689 shares of the medical research company's stock worth $8,224,000 after buying an additional 4,163 shares during the period. Finally, MassMutual Private Wealth & Trust FSB boosted its stake in Agilent Technologies by 32.7% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,777 shares of the medical research company's stock worth $210,000 after buying an additional 438 shares during the period.

Analyst Upgrades and Downgrades

A has been the subject of several recent analyst reports. Robert W. Baird lifted their price objective on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a research note on Thursday, August 28th. Evercore ISI lowered their target price on shares of Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating for the company in a research note on Thursday, August 28th. Barclays reissued an "equal weight" rating and set a $125.00 target price on shares of Agilent Technologies in a research note on Friday, August 29th. JPMorgan Chase & Co. decreased their price objective on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a report on Thursday, May 29th. Finally, Wall Street Zen lowered shares of Agilent Technologies from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $140.08.

Agilent Technologies Stock Up 0.7%

NYSE:A traded up $0.95 during mid-day trading on Thursday, reaching $127.67. The company's stock had a trading volume of 1,513,219 shares, compared to its average volume of 1,788,538. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The stock has a fifty day moving average of $120.19 and a 200-day moving average of $115.94. The firm has a market capitalization of $36.19 billion, a PE ratio of 29.97, a price-to-earnings-growth ratio of 3.94 and a beta of 1.24. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts' consensus estimates of $1.37. The company had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm's revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be issued a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies's payout ratio is currently 23.24%.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the business's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer directly owned 37,448 shares in the company, valued at approximately $4,397,893.12. The trade was a 3.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.